Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials

Journal of the National Cancer Institute

Volumn 105, Issue 13, 2013, Pages 954-959

  Abrams, Jeffrey S ^a   Mooney, Margaret M ^a   Zwiebel, James A ^a   Korn, Edward L ^a   Friedman, Steven H ^a   Finnigan, Shanda R ^a   Schettino, Patricia R ^a   Denicoff, Andrea M ^a   Kruhm, Martha G ^a   Montello, Mike ^a   Misra, R Rita ^a   Ansher, Sherry S ^a   Dipiazza, Kate J ^b   Souhan, Erin M ^b   Wickerham, D Lawrence ^c   Giantonio, Bruce J ^d   O'Donnell, Robert T ^e   Sullivan, Daniel M ^f   Soto, Nancy I ^g   Fleming, Gini F ^h   Prindiville, Sheila A ^a   Petryshyn, Ray A ^a   Hautala, Judith A ^j   Grad, Oren ^j   Zuckerman, Brian L ^j   Meyer, Ralph M ⁱ   Yao, James C ^k   Baker, Laurence A ^m   Buckner, Jan C ⁿ   Hortobagyi, Gabriel N ^l   Doroshow, James H ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b EMMES CORPORATION   (United States)

^c National Surgical Adjuvant Breast   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g RADIATION THERAPY ONCOLOGY GROUP   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ QUEEN S UNIVERSITY   (Canada)

^j Science and Technology Policy Institute   (United States)

^k Gastrointestinal Medical Oncology Department   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m UNIVERSITY OF MICHIGAN   (United States)

ⁿ MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CENTER; CLINICAL PROTOCOL; COMMUNITY; EXPERIENCE; HEALTH CARE PLANNING; HUMAN; NATIONAL HEALTH ORGANIZATION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; STAFF;

CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; GUIDELINES AS TOPIC; HUMANS; MULTICENTER STUDIES AS TOPIC; NATIONAL CANCER INSTITUTE (U.S.); TIME FACTORS; UNITED STATES;

EID: 84880211812     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt137     Document Type: Article

References (10)

1. Institute of Medicine. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: Institute of Medicine of the National Academies; 2010.
2. National Cancer Institute. Report of the Clinical Trials Working Group of the National Cancer Advisory Board: Restructuring the National Cancer Clinical Trials Enterprise. 2005. http://ccct.cancer.gov/about/reports#clinical-trials. Accessed May 13, 2013.
3. National Cancer Institute. Report of the Operational Efficiency Working Group of the Clinical Trials and Translational Research Advisory Committee, Compressing the Timeline for Cancer Clinical Trial Activation, March 2010. http://ccct.cancer.gov/files/OEWG-Report. Accessed May 13, 2013.
4. Cheng SK, Dietrich MS, Dilts DM. A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of Cancer Therapy Evaluation Program (NCI-CTEP) sponsored studies. Clin Cancer Res. 2010;16(22):5557-5563.
5. Dilts DM, Cheng SK, Crites JS, Sandler AB, Doroshow JH. Phase III clinical trial development: a process of chutes and ladders. Clin Cancer Res. 2010;16(22):5381-5389.
6. National Cancer Institute. Industry Collaborations. http://ctep.cancer. gov/industryCollaborations2/intellectual-property.html. Accessed March 26, 2012.
7. CEO Life Sciences Consortium. CEO Roundtable on Cancer Life Sciences Consortium. http://ceo-lsc.org/. Accessed March 26, 2012.
8. Wagner TH, Murray C, Goldberg J, Adler JM, Abrams J. Costs and benefits of the National Cancer Institute Central Institutional Review Board. J Clin Oncol. 2009;28(4):662-666.
9. Emanuel EJ, Menikoff J. Reforming the regulations governing research with human subjects. N Engl J Med. 2011;365(12):1145-1150.
10. Menikoff JD. The paradoxical problem with multiple-IRB review. N Engl J Med. 2010;363(17):1591-1593.